RMD Valuation

Resmed Inc

Add to Watchlist

Advanced Chart

275.160

+1.66(0.607%)1D

Overview
Forecast
Valuation
Earnings

RMD Relative Valuation

RMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RMD is overvalued; if below, it's undervalued.

Historical Valuation

Resmed Inc (RMD) is now in the Fair zone, suggesting that its current forward PE ratio of 26.84 is considered Fairly compared with the five-year average of 31.07. The fair price of Resmed Inc (RMD) is between 259.82 to 391.77 according to relative valuation methord.

Relative Value

Fair Zone

259.82-391.77

Current Price：275.16

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

7.21

P/B

Median3y

7.05

Median5y

8.72

3.92

FCF Yield

Median3y

2.82

Median5y

2.43

Competitors Valuation Multiple

The average P/S ratio for RMD's competitors is 4.51, providing a benchmark for relative valuation. Resmed Inc Corp (RMD) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 7.92%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap